JRSIS Health Care
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of JRSIS Health Care generated cash of $516,724, which is less than the previous year. Cash used in financing activities reached the amount of -$568,365 last year. Net change in cash is therefore -$40,699.
Cash Flow
| 2014 | 2.05M | -4.18M | 2.53M |
|---|---|---|---|
| 2015 | 2.53M | -4.53M | 1.33M |
| 2016 | 4.98M | -3.61M | -776.19K |
| 2017 | 8.33M | -13.46M | 5.16M |
| 2018 | 9.19M | -5.96M | -3.92M |
| 2019 | 11.84M | -3.96M | -6.10M |
| 2020 | 10.64M | -8.27M | -3.43M |
| 2021 | 8.23M | -5.50M | -2.79M |
| 2022 | 3.06M | -2.82M | -738.24K |
| 2023 | 516.72K | 18.88K | -568.36K |
JRSS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 158.81K | 855.97K | 844.82K | 1.97M | 256.45K | 884.29K | 890.66K | 352.15K | 1.04M | 631.28K |
Operating activities | ||||||||||
Net income | -80.91K | -327.63K | 3.18M | 3.82M | 1.26M | 2.84M | 6.63M | 5.01M | 2.63M | 941.10K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 58.01K | 19.10K | 3.31M | 2.69M | 2.21M | 1.76M | 1.26M | 1.08M | 871.94K | 175.30K |
Stock-based compensation expense | 0 | 245.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 245.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 10.65K | -3.84K | -2.98M | 492.43K | 3.55M | -2.95M | -2.04M | -1.52M | -1.44M | -392.31K |
Inventories | 128.66K | 3.84K | -269.21K | -310.69K | 76.65K | -288.67K | -78.43K | -349.86K | -341.69K | -83.03K |
Accounts payable | 538.25K | -41.28K | 5.23M | 2.80M | 30.17K | 1.96M | 1.26M | 432.61K | 80.10K | 216.68K |
Cash generated by operating activities | 516.72K | 3.06M | 8.23M | 10.64M | 11.84M | 9.19M | 8.33M | 4.98M | 2.53M | 2.05M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.48K | -44.64K | -5.50M | -8.27M | -3.96M | -5.96M | -13.49M | -3.61M | -5.15M | -4.24M |
Acquisitions Net | 20.36K | 0 | 0 | 0 | 750.95K | 0 | 29.08K | 0 | 621.14K | 0 |
Cash generated by investing activities | 18.88K | -2.82M | -5.50M | -8.27M | -3.96M | -5.96M | -13.46M | -3.61M | -4.53M | -4.18M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 927.59K | 141.42K | 414.55K | 46.8K | 140K | 903.15K | 0 | 178.04K | 918.29K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -553.89K | 930.69K | -4.04M | -4.38M | -5.48M | -4.06M | 4.26M | -3.29M | 2.25M | -1.59M |
Cash used in financing activities | -568.36K | -738.24K | -2.79M | -3.43M | -6.10M | -3.92M | 5.16M | -776.19K | 1.33M | 2.53M |
Net Change In Cash | -40.69K | -797.35K | 11.14K | -1.12M | 1.71M | -627.84K | -6.37K | 538.50K | -694.33K | 415.19K |
Cash at end of period | 118.11K | 58.61K | 855.97K | 844.82K | 1.97M | 256.45K | 884.29K | 890.66K | 352.15K | 1.04M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |